4.6 Editorial Material

ADRENAL CANCER IN 2013 Time to individualize treatment for adrenocortical cancer?

Journal

NATURE REVIEWS ENDOCRINOLOGY
Volume 10, Issue 2, Pages 76-78

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nrendo.2013.263

Keywords

-

Funding

  1. Intramural NIH HHS Funding Source: Medline

Ask authors/readers for more resources

2013 was a good year for adrenocortical cancer, as the new knowledge gained holds great promise for patients. Advances were made in genetics, epigenetics, the advent of related technological and bioinformatic tools, and the feasibility of massive screening of people and samples.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available